GlassScriptPhysician profile
Asha Jamzadeh
NPI 1346668696
$20,876.59
in general payments reported to CMS, 2019-2025
8 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,313 · 2020: $1,117 · 2021: $3,021 · 2022: $134 · 2024: $351 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $2,440 · Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,000.00 |
| Travel and Lodging | $2,440.17 |
| Food and Beverage | $851.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $14,802.99 | 2025 | 1788 |
| Davol INC. | $3,021.15 | 2021 | |
| Boston Scientific Corporation | $1,487.26 | 2019-2024 | Ams 700, Rezum Generator |
| Coloplast Corp | $1,384.53 | 2019-2025 | |
| Olympus America INC. | $121.83 | 2022 | |
| Ferring Pharmaceuticals INC. | $30.88 | 2025 | Adstiladrin |
| Janssen Biotech, INC. | $15.41 | 2025 | Erleada |
| Rochester Medical Corporation | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asha Jamzadeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.